| Aktie | Ticker | 2025/Q4 | 2025/Q3 | 2025/Q2 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | ||
| 186.779.622 $ | +97.940.800 $ | +83,4 % | 101.502.599 $ | +37.326.916 $ | +57,4 % | 84.456.465 $ | +10.822.760 $ | +31,0 % | ||
| BANK OF AMERICA CORP /DE/ | BAC | 171.279.492 $ | +95.314.470 $ | +125,5 % | 75.965.022 $ | +25.196.741 $ | +49,6 % | 50.768.281 $ | -3.884.416 $ | -7,1 % |
| SOLENO THERAPEUTICS INC | SLNO | 7.011.632 $ | +5.630.361 $ | +407,6 % | ||||||
| Zai Lab Ltd | ZLAB | 3.472.487 $ | -3.326.796 $ | -48,9 % | 6.799.283 $ | +2.082.005 $ | +44,1 % | 4.717.278 $ | -5.942.107 $ | -55,7 % |
| Savara Inc | SVRA | 6.001.979 $ | +1.328.006 $ | +28,4 % | 4.673.973 $ | +2.130.909 $ | +83,8 % | 2.543.064 $ | -133.318 $ | -5,0 % |
| Jazz Pharmaceuticals plc | JAZZ | 5.389.697 $ | +709.062 $ | +15,1 % | 4.680.635 $ | +4.680.635 $ | ||||
| NEUROCRINE BIOSCIENCES INC | NBIX | 5.104.020 $ | +5.104.020 $ | |||||||
| UNITED THERAPEUTICS Corp | UTHR | 4.605.000 $ | +3.204.456 $ | +228,8 % | 1.400.544 $ | +1.400.544 $ | ||||
| IONIS PHARMACEUTICALS INC | IONS | 3.882.529 $ | +3.882.529 $ | |||||||
| NEKTAR THERAPEUTICS | NKTR | 2.917.263 $ | +2.917.263 $ | |||||||
| INSMED Inc | INSM | 2.849.382 $ | +1.382.957 $ | +94,3 % | 1.466.425 $ | +1.466.425 $ | ||||
| Sanofi | SNY | 2.379.210 $ | +2.379.210 $ | |||||||
| CYTOKINETICS INC | CYTK | 2.018.843 $ | -914.705 $ | -31,2 % | ||||||
| GENMAB A/S | GMAB | 898.190 $ | +898.190 $ | |||||||
| MoonLake Immunotherapeutics | MLTX | 831.806 $ | -424.099 $ | -33,8 % | ||||||
| NovaBridge Biosciences | NBP | 528.769 $ | +528.769 $ | |||||||
| PALATIN TECHNOLOGIES INC | PTNT | 522.474 $ | +522.474 $ | |||||||
| BARCLAYS PLC | BCS | 31.408 $ | -43.109 $ | -57,9 % | ||||||
| 186.779.622 $ | +97.940.800 $ | +83,4 % | 101.502.599 $ | +37.326.916 $ | +57,4 % | 84.456.465 $ | +10.822.760 $ | +31,0 % | ||